Flebogamma® 5% Human Normal Immunoglobulin for Intravenous Administration Pure Confidence.

Slides:



Advertisements
Similar presentations
WFH Bangkok 2004 Nanotiv – Factor IX Concentrate Plasma-derived, Very High Purity Factor IX Concentrate.
Advertisements

Dock to Stock at Skyline Biotech A brief Outline of how we make our product at Skyline Biotech.
When can you use an antibody to find another antibody?
Viruses can be lipid-coated or non- enveloped. Virus inactivation works by one of the following two mechanisms:  By attacking the viral envelope or capsid.
Control of Microbial Growth. A few terms Bacteriostatic: inhibits bacterial growth Bactericidal: something capable of killing bacteria Antiseptic: an.
WFH Bangkok 2004 Octanine F – Factor IX at its Peak Very High Purity Factor IX Virus Inactivation and Elimination Haemophilia B Treatment and Prophylaxis.
WFH Bangkok 2004 Octanate – Factor VIII with the Safety Factor VWF High Purity Plasma-Derived Factor VIII Double Virus Inactivated Haemophilia A Treatment.
LOGO In the Name of GOD. LOGO مصرف پلاکت و فرآورده های پلاسمائی شیراز خرداد 1393 دکتر آزیتا آذرکیوان متخصص کودکان؛ فوق تخصص هماتولوژی انکولوژی.
Dept. Of Antitoxin King Institute of Preventive Medicine Snake Venom Anti Sera against 1.Naja naja 2.Vipera russelli 3.Bungarus caeruleus 4.Echis carinatus.
BLOOD BANKING 1- BLOOD PRODUCTS 2- AUTOLOGOUS TRANSFUSION M. H. Shaheen Maadi Armed Forces Hospital.
Principles of purification of macromolecules Genetics 222 Method and Logic in Experimental Genetics Reference Protein Purification: Principles and Practice.
Octaplex – The Modern PCC
1 Douglas C. Lee, PhD Plasma Protein Therapeutics Association BPAC April 2011 Plasma Protein Therapies.
BLOOD TRANSFUSION Begashaw M (MD).
Unit 2 Blood and Blood Components
Immunohematology (Blood Bank) CLS 245. What is Immunohematology? It is the study of Antigen-Antibody reaction as they relate to blood disorder.
Xcellerex … speeding medicines to people … PAT for Biologics Ensuring Quality of Biologically Produced Drugs FDA Advisory Committee on Pharmaceutical Sciences.
Hämosan ® Life Science Services GmbH A-8262 Ilz, Neudorf 41 Tel. +43 (0) 3385/8117 mail: Trainings and much more...
New Treatment Modalities; Recombinant Factor VIII Products – “Factor VIII after 2008” (More Choices) Gita V. Massey, MD June 20, 2009.
Analysis of Proteins and Peptides Amino acid composition Molecular weight Isoelectric point Subunit structure Prosthetic groups Solubility Biological activity.
Evaluation of Viral Clearance Studies
Immunology ANTIBODIES we have ~10 12 antibodies made against foreign viruses, bacteria, parasites (vaccines) antibodies combine with foreign antigens to.
BLOOD COMPONENT PREPARATION
Copyright © 2010 Pearson Education, Inc. Antibodies Immunoglobulins—gamma globulin portion of blood Proteins secreted by plasma cells Capable of binding.
ERT 313 BIOSEPARATION ENGINEERING INTRODUCTION Prepared by: Miss Hairul Nazirah Abdul Halim.
Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.
Cold ethanol precipitation and calcium-phosphate flocculation of recombinant antibodies University of Natural Resources and Life Sciences Vienna, Austria.
Antibody Array Assay Report 1. Protocol 2 Protein Extraction 1.Wash the cells with ice cold 1X PBS. 2.Add Lysis Beads and Extraction Buffer to the sample.
TSE Clearance in Plasma Derivatives TSE Advisory Committee February 8, 2005 Dorothy Scott, M.D. DH/OBRR/CBER/FDA.
Preparation of blood components
Evaluation of Viral Clearance Studies Mahmood Farshid, Ph.D. Div. Of Hematology OBRR/ CBER/FDA.
TSE Task Force Prion reduction evaluation in the manufacturing of plasma protein therapies Dr. Henry Baron, Chair, PPTA TSE Task Force.
ERT 313 BIOSEPARATION ENGINEERING INTRODUCTION
February 24, 2016 | 1 Paul Strengers MD, FFPM Sanquin Blood Supply Amsterdam The Netherlands Risk assessment schemes: Impact of.
PHYSICAL AND CHEMICAL INFLUENCES ON VIRAL INFECTIVITY
Lectures on Hematology for 2 nd medical students Dr.Baybeen Selevany Assist. Professor PhD( Hematology), M.Sc( Heart) Dept. Of Medical Physiology.
Plasma fractionation and viral inactivation/removal procedures
Lab 6 Ig Purification What will the Ig be used for? How pure does it need to be? What is the source of the antibody (serum, ascites, cell culture supernatant)
Antibodies Heroes of the humoral response 1/25/11 Lab #3 Adaptive immunity.
Plasmid Purification Miniprep
Analysis of human parvovirus B19 components and strategies of non-enveloped virus removal from factor VIII concentrates Japanese Red Cross Plasma Fractionation.
Lab Activity 11 Purification of LDH Part II
Lab Activity 12 Purification of LDH Part II
Serum albumin Albunex Optison™ IV infusion
Human rabies virus immune globulin
Hepatitis B immune globulin
Human Serum Albumin (DB00062) Approved Drug
Human clostridium tetani toxoid immune globulin
Human Parvovirus PARV4 in Blood and Plasma Products
DNA ISOLATION: Strawberry Lab
Human Varicella-Zoster Immune Globulin
Effector mechanisms of humoral immunity
פקטורי קרישה- כל מה שרציתם לדעת (כמעט) ולשאול
Separation Techniques
QUESTIONS ASKED IN EXAM
Control of Microorganisms by Physical and Chemical Agents
Lysis of Cell Wall: 1. First stage is the weakening of cell wall:
Viral Safety of Blood Products in Taiwan
Biochemical Methodology
Blood Components MLAB 2431 Immunohematology
Antimicrobial Agents and Immunology
Lab Activity 11 Purification of LDH Part II
Principles of purification of macromolecules
NORTH AMERICAN GINSENG ROOT
Down stream Processing
Heparanase improves mouse embryo implantation
Blood Components Dosage And Their Administration
Practical Blood Bank Lab 11 Cyroglobulin.
IVIg Therapy. IVIg Therapy What are Immunoglobulins? Immunoglobulins, also known as antibodies, are proteins that bind specifically to antigens Immunoglobulin.
Presentation transcript:

Flebogamma® 5% Human Normal Immunoglobulin for Intravenous Administration Pure Confidence

Flebogamma® 5%: Plasma Safety Grifols monitors the entire plasma production process from start to finish. All Grifols products are subjected to rigorous donor screening, testing and viral elimination (inactivation and removal) processes to enhance their quality and safety. Grifols has been awarded the Quality Standards of Excellence Assurance and Leadership (QSEAL) by the Plasma Protein Therapeutics Association (PPTA).

Flebogamma® 5%: Processing plasma More than 10 years of experience and know-how 4 5 8 10 15 1 2 3 6 7 9 11 12 13 14 16 17 18 19 20 21 1 - Frozen Plasma 2 – Thawing & Centrifugation 3 - Cryoprecipitate 4 – Cryoprecipitate-Poor Plasma 5 - Cold Ethanol Fractionation 6 - Centrifugation & Filtration 7 - Fraction II + III Precipitate 8 - Supernatant 9 - Centrifugation & Filtration 10 -Precipitate 11 - Stabilization with D-Sorbitol 12 - Pasteurization (60oC, 10 hours)* 13 - PEG Precipitation* 14 - Centrifugation & Filtration 15 - Supernatant 16 – DEAE - Sephadex Chromatography 17 - Concentration and pH Adjustment 18 - Centrifugation & Filtration 19 - Sterile Filtrations 20 - QC Testing Quarantine 21 - Flebogamma® 5% *Viral elimination methods

Flebogamma® 5%: Viral Safety Flebogamma® 5% was one of the first liquid immune globulins products to incorporate pasteurization as a viral inactivation method. Pasteurization has been validated to achieve significant inactivation of both enveloped and non-enveloped viruses. Grifols developed a method of pasteurization (heat treatment at 60ºC 10 h) using sorbitol as a stabilizer, which avoids denaturalization of proteins and preserves antibody activity.

Flebogamma® 5%: Pure Confidence High Purity Ig purity: 99.37% ± 0.26 (n= 220 consecutive lots)

Flebogamma® 5%: Pure Confidence High Purity Monomers + Dimers content: > 99.9% (n= 220 consecutive lots)

Flebogamma® 5%: Pure Confidence High Purity Fragments: Not detectable (n= 220 consecutive lots)

Flebogamma® 5%: Pure Confidence High Tolerability IgA content: 0.011 ± 0.003 mg/ml (n= 220 consecutive lots)

Flebogamma® 5%: Pure Confidence High Tolerability Anticomplementary Activity: 0.27 ± 0.06 CH50/mgIg (n= 220 consecutive lots)

Flebogamma® 5%: Pure Confidence High Tolerability Pre-kallikrein Activator: <2 I.U. (n= 220 consecutive lots)

Flebogamma® 5%: Pure Confidence Physiologic Isotonic solution: 328.6 ± 0.26 mOsm/Kg (n= 220 consecutive lots)

Flebogamma® 5%: Pure Confidence Physiologic Normal pH: 5.60 ± 0.07 (n= 220 consecutive lots)